Startups

A biotechnology company developing intracellular genetic protein therapy to treat chronic heart failure

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 23,000 COMPANIES →

Summary

Seedtable Score

Score icon 63

Locations

Last Stage Round

Total Funding
$6.3M

Investors

Full Company Profile